Table 2.
Western Blot Data on EIA-negative Prefrontal Cortex Specimens from Autopsy Cases at Gunma Cancer Center
| Case | Age | Gender | Postmortem delay (h) | ApoE | Aβ40(BA27) | Aβ42(BC05) | ||
|---|---|---|---|---|---|---|---|---|
| 4kd | 8kd | 4kd | 8kd | |||||
| 2 | 60 | F | 2.8 | 3 /3 | ± | − | − | + |
| 3 | 56 | M | 0.8 | 3 /3 | − | − | − | + 1.2* |
| 5 | 66 | M | 2.0 | 3 /3 | − | − | − | + |
| 6 | 71 | M | 0.8 | 3 /4 | − | ± ↓ | − | + 3.3 |
| 10 | 70 | M | 2.0 | 3 /3 | ± | − | − | + 0.6 |
| 13 | 79 | F | 10.3 | 2 /3 | − | ± ↓ | − | + 5.1 |
| 14 | 48 | F | 1.75 | 3 /4 | − | − | − | + 1.8 |
| 20 | 44 | M | 7.7 | 3 /4 | − | − | − | − |
| 21 | 70 | M | 1.5 | 3 /3 | − | − | ± 4.0 | + 2.0 |
| 23 | 53 | M | 4.8 | 3 /4 | − | − | − | − |
| 24 | 51 | M | 1.2 | 3 /3 | − | ± ↓ | − | − |
| 25 | 69 | F | 10.0 | 3 /3 | − | − | − | + ↓ |
| 26 | 55 | M | 2.0 | 3 /3 | − | − | − | − |
| 27 | 65 | M | 7.5 | 3 /4 | − | − | − | − |
| 28 | 68 | M | 2.0 | 3 /3 | − | ± 3.5 | − | + 2.6 |
| 29 | 57 | M | 1.0 | 3 /3 | − | 2+ ↑ | − | + ↓ |
| 31 | 75 | F | 2.0 | 2 /3 | − | ± ↓ | − | + 2.3 |
| 32 | 49 | M | 1.5 | 3 /3 | − | ± ↓ | − | + 1.3 |
| 36 | 73 | M | 8.0 | 3 /3 | − | − | − | + 1.9 |
| 38 | 60 | M | 2.5 | 3 /3 | − | − | − | + 1.3 |
| 39 | 40 | F | 8.4 | 3 /3 | − | − | − | + 1.9 |
| 40 | 67 | M | 0.67 | 3 /3 | − | − | + | + 2.0 |
−, negative; ±, faint signal; +, definite signal; 2+, strong signal; ↓, below the quantitation range; ↑, beyond the linear range; *, pmol/g wet weight.